On September 24, 2026, Nanobiotix is trading at $31.70, down 10.05%, amid a broader biotechnology selloff.
- XBI is down 2.04%; elevated Treasury yields and inflation concerns are pressuring growth-oriented biotech stocks.
- No fresh company-specific negative announcement was identified; the latest substantive company update reported positive Phase 1 results on September 14. The move appears sector-driven rather than related to Nanobiotix fundamentals.